Antibody-directed evolution reveals a mechanism for enhanced neutralization at the HIV-1 fusion peptide site

Antibody-directed evolution reveals a mechanism for enhanced neutralization at the HIV-1 fusion peptide site

Abstract The HIV-1 fusion peptide (FP) represents a promising vaccine target, but global FP sequence diversity among circulating strains has limited anti-FP antibodies to ~60% neutralization breadth. Here we evolve the FP-targeting antibody VRC34.01 in vitro to enhance FP-neutralization using site s...

Full description

Bibliographic Details
Main Authors:	Bailey B. Banach, Sergei Pletnev, Adam S. Olia, Kai Xu, Baoshan Zhang, Reda Rawi, Tatsiana Bylund, Nicole A. Doria-Rose, Thuy Duong Nguyen, Ahmed S. Fahad, Myungjin Lee, Bob C. Lin, Tracy Liu, Mark K. Louder, Bharat Madan, Krisha McKee, Sijy O’Dell, Mallika Sastry, Arne Schön, Natalie Bui, Chen-Hsiang Shen, Jacy R. Wolfe, Gwo-Yu Chuang, John R. Mascola, Peter D. Kwong, Brandon J. DeKosky
Format:	Article
Language:	English
Published:	Nature Portfolio 2023-11-01
Series:	Nature Communications
Online Access:	https://doi.org/10.1038/s41467-023-42098-5

Similar Items

Extended antibody-framework-to-antigen distance observed exclusively with broad HIV-1-neutralizing antibodies recognizing glycan-dense surfaces
by: Myungjin Lee, et al.
Published: (2021-11-01)

Mapping monoclonal anti-SARS-CoV-2 antibody repertoires against diverse coronavirus antigens
by: Matheus Oliveira de Souza, et al.
Published: (2022-09-01)

Removal of variable domain N-linked glycosylation as a means to improve the homogeneity of HIV-1 broadly neutralizing antibodies
by: Gwo-Yu Chuang, et al.
Published: (2020-01-01)

Improved HIV-1 neutralization breadth and potency of V2-apex antibodies by in silico design
by: Graham T. Holt, et al.
Published: (2023-07-01)

Isolation of broadly neutralizing HIV-1 antibodies from high-throughput single B cell culture
by: Longo NS, et al.
Published: (2012-09-01)

Bispecific antibody CAP256.J3LS targets V2-apex and CD4-binding sites with high breadth and potency
by: Baoshan Zhang, et al.
Published: (2023-12-01)

Rational design of a trispecific antibody targeting the HIV-1 Env with elevated anti-viral activity
by: James J. Steinhardt, et al.
Published: (2018-02-01)

Mapping monoclonal anti-SARS-CoV-2 antibody repertoires against diverse coronavirus antigens
by: DeKosky, Brandon J.
Published: (2022)

Structure of Super-Potent Antibody CAP256-VRC26.25 in Complex with HIV-1 Envelope Reveals a Combined Mode of Trimer-Apex Recognition
by: Jason Gorman, et al.
Published: (2020-04-01)

Structures of HIV-1 Neutralizing Antibody 10E8 Delineate the Mechanistic Basis of Its Multi-Peak Behavior on Size-Exclusion Chromatography
by: Young Do Kwon, et al.
Published: (2021-06-01)

[18F]-T807 tauopathy PET imaging in chronic traumatic encephalopathy [v1; ref status: indexed, http://f1000r.es/4fb]
by: Sam Gandy, et al.
Published: (2014-09-01)

Rhesus Macaque B-Cell Responses to an HIV-1 Trimer Vaccine Revealed by Unbiased Longitudinal Repertoire Analysis
by: Kaifan Dai, et al.
Published: (2015-12-01)

The Molecular Mechanisms That Underlie the Immune Biology of Anti-drug Antibody Formation Following Treatment With Monoclonal Antibodies
by: Anna Vaisman-Mentesh, et al.
Published: (2020-08-01)

Highly protective antimalarial antibodies via precision library generation and yeast display screening
by: Banach, Bailey B, et al.
Published: (2022)

Surface-Matrix Screening Identifies Semi-specific Interactions that Improve Potency of a Near Pan-reactive HIV-1-Neutralizing Antibody
by: Young D. Kwon, et al.
Published: (2018-02-01)

Improved pharmacokinetics of HIV-neutralizing VRC01-class antibodies achieved by reduction of net positive charge on variable domain
by: Young D. Kwon, et al.
Published: (2023-12-01)

Mapping Polyclonal HIV-1 Antibody Responses via Next-Generation Neutralization Fingerprinting.
by: Nicole A Doria-Rose, et al.
Published: (2017-01-01)

A matrix of structure-based designs yields improved VRC01-class antibodies for HIV-1 therapy and prevention
by: Young D. Kwon, et al.
Published: (2021-01-01)

Quantification of the Impact of the HIV-1-Glycan Shield on Antibody Elicitation
by: Tongqing Zhou, et al.
Published: (2017-04-01)

Association between single moderate to severe traumatic brain injury and long-term tauopathy in humans and preclinical animal models: a systematic narrative review of the literature
by: Ariel Walker, et al.
Published: (2022-01-01)

B cell recognition of the conserved HIV-1 co-receptor binding site is altered by endogenous primate CD4.
by: Mattias N E Forsell, et al.
Published: (2008-10-01)

Engineering of HIV-1 neutralizing antibody CAP256V2LS for manufacturability and improved half life
by: Baoshan Zhang, et al.
Published: (2022-10-01)

Optical Neuroimaging in Delirium
by: Shixie Jiang, et al.
Published: (2023-12-01)

Soluble prefusion-closed HIV-envelope trimers with glycan-covered bases
by: Adam S. Olia, et al.
Published: (2023-08-01)

Cell activation-based screening of natively paired human T cell receptor repertoires
by: Ahmed S. Fahad, et al.
Published: (2023-05-01)

HIV-1 neutralizing antibodies elicited in humans by a prefusion-stabilized envelope trimer form a reproducible class targeting fusion peptide
by: Shuishu Wang, et al.
Published: (2023-07-01)

Prevalence and trend of central nervous system–active medication polypharmacy among US commercially insured adults with vs without early-onset dementia: a multi-year cross-sectional study
by: Yu-Jung Jenny Wei, et al.
Published: (2024-02-01)

Newcastle Disease Virus-Like Particles Displaying Prefusion-Stabilized SARS-CoV-2 Spikes Elicit Potent Neutralizing Responses
by: Yongping Yang, et al.
Published: (2021-01-01)

454 pyrosequencing and bioinformatics analysis of the lineage of the broad and potent gp41-directed antibody 10e8
by: Ofek G, et al.
Published: (2012-09-01)

Immortalization and functional screening of natively paired human T cell receptor repertoires
by: Fahad, Ahmed S, et al.
Published: (2022)

Functional Profiling of Antibody Immune Repertoires in Convalescent Zika Virus Disease Patients
by: Ahmed S. Fahad, et al.
Published: (2021-02-01)

Structural basis of glycan276-dependent recognition by HIV-1 broadly neutralizing antibodies
by: Christopher A. Cottrell, et al.
Published: (2021-11-01)

Molecular probes of spike ectodomain and its subdomains for SARS-CoV-2 variants, Alpha through Omicron
by: Teng, I-Ting, et al.
Published: (2022)

Molecular probes of spike ectodomain and its subdomains for SARS-CoV-2 variants, Alpha through Omicron.
by: I-Ting Teng, et al.
Published: (2022-01-01)

Molecular probes of spike ectodomain and its subdomains for SARS-CoV-2 variants, Alpha through Omicron
by: I-Ting Teng, et al.
Published: (2022-01-01)

Antibody screening at reduced pH enables preferential selection of potently neutralizing antibodies targeting SARS‐CoV ‐2
by: Madan, Bharat, et al.
Published: (2022)

Assessment of Crosslinkers between Peptide Antigen and Carrier Protein for Fusion Peptide-Directed Vaccines against HIV-1
by: Li Ou, et al.
Published: (2022-11-01)

A transfer learning approach based on gradient boosting machine for diagnosis of Alzheimer’s disease
by: Mehdi Shojaie, et al.
Published: (2022-10-01)

Cholinergic forebrain degeneration in the APPswe/PS1ΔE9 transgenic mouse
by: Sylvia E. Perez, et al.
Published: (2007-10-01)

Avoiding Death by Meeting: An Interactive Workshop for Academic Faculty Highlighting Strategies to Facilitate Effective Team Meetings
by: Sarah Merriam, et al.
Published: (2021-03-01)